Curative potential of nonoperative treatment strategies for adenocarcinoma of the esophagogastric junction

被引:0
作者
Stahl, M. [1 ]
Stuschke, M. [2 ]
机构
[1] Evang Kliniken Essen Mitte, Klin Internist Onkol & Hamatol, Henricistr 92, D-45136 Essen, Germany
[2] Klinikum Univ Duisburg Essen, Klin & Poliklin Strahlentherapie, Essen, Germany
来源
ONKOLOGE | 2019年 / 25卷 / 12期
关键词
Surgery; Definitive chemoradiotherapy; Curative treatment; Retrospective cohort studies; Complete remission; ESOPHAGEAL CANCER; NEOADJUVANT CHEMORADIOTHERAPY; DEFINITIVE CHEMORADIOTHERAPY; RECURRENCE PATTERNS; SALVAGE SURGERY; CHEMORADIATION; THERAPY; CETUXIMAB; SURVIVAL; PLUS;
D O I
10.1007/s00761-019-00665-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Due to comorbidities and high age patients with localized adenocarcinoma of the esophagogastric junction (AEGJ) often have contraindications for surgery. Objective This raises the question of whether there are curative treatment options without surgery. Material and methods Following a nonsystematic search of the literature the published data on definitive chemoradiotherapy are reported. Results Retrospective cohort studies from centers in western countries show that patients with resectable AEGJ can have long-term survival and can possibly be cured by definitive chemoradiotherapy. Conclusion The treatment option of definitive chemoradiotherapy needs to be discussed in the interdisciplinary tumor board, not only for patients with squamous cell cancer of the esophagus but also for those with AEGJ. This is particularly true if complete remission has been clinically achieved.
引用
收藏
页码:1095 / 1102
页数:8
相关论文
共 50 条
[21]   Multimodal Treatment and Supportive Care of Advanced Adenocarcinoma of the Esophagogastric Junction [J].
Block, Andreas ;
Arnold, Dirk .
VISZERALMEDIZIN, 2012, 28 (02) :121-127
[22]   Adenocarcinoma of the esophagogastric junction: Neoadjuvant radiochemotherapy and radical surgery [J].
Leibl, Bernhard J. ;
Vitz, Stephanie ;
Schaefer, Wolfgang ;
Alfrink, Martin ;
Gschwendtner, Andreas ;
Grabenbauer, Gerhard G. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (04) :231-237
[23]   Treatment of esophago-gastric junction adenocarcinoma [J].
de Manzoni, Giovanni ;
Zanoni, Andrea ;
Giacopuzzi, Simone .
ANNALI ITALIANI DI CHIRURGIA, 2012, 83 (03) :208-214
[24]   Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction [J].
Wang, Wen-Ping ;
Wang, Kang-Ning ;
Gao, Qiang ;
Chen, Long-Qi .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
[25]   Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction Possibilities and clinical consequences [J].
Gockel, I. ;
Lordick, F. ;
Lyros, O. ;
Kreuser, N. ;
Hoelscher, A. H. ;
Wittekind, C. .
CHIRURG, 2020, 91 (01) :41-50
[26]   Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction [J].
Xiong, Jianping ;
Wang, Yaqin ;
Kang, Wenzhe ;
Ma, Fuhai ;
Liu, Hao ;
Ma, Shuai ;
Li, Yang ;
Jin, Peng ;
Hu, Haitao ;
Tian, Yantao .
FRONTIERS IN ONCOLOGY, 2020, 10
[27]   Treatment Strategies for the Optimal Management of Locally Advanced Pancreatic Adenocarcinoma With Curative Intent A Systematic Review [J].
Attard, Joseph A. ;
Farrugia, Alexia ;
Pathanki, Adithya ;
Roberts, Keith J. ;
Dasari, Bobby ;
Isaac, John ;
Ma, Yuk Ting ;
Chatzizacharias, Nikolaos A. .
PANCREAS, 2020, 49 (10) :1264-1275
[28]   Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States † [J].
Kim, Bradford J. ;
Chiang, Yi-Ju ;
Das, Prajnan ;
Minsky, Bruce D. ;
Blum, Mariela A. ;
Ajani, Jaffer A. ;
Estrella, Jeannelyn S. ;
Hofstetter, Wayne L. ;
Tzeng, Ching-Wei D. ;
Badgwell, Brian D. ;
Mansfield, Paul F. ;
Ikoma, Naruhiko .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) :1-16
[29]   Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction [J].
Chen, Xin-Zu ;
Zhang, Wei-Han ;
Hu, Jian-Kun .
CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (03) :237-242
[30]   The optimal lymph node dissection in patients with adenocarcinoma of the esophagogastric junction [J].
Okholm, Cecilie ;
Fjederholt, Kaare Terp ;
Mortensen, Frank Viborg ;
Svendsen, Lars Bo ;
Achiam, Michael Patrick .
SURGICAL ONCOLOGY-OXFORD, 2018, 27 (01) :36-43